Articles for the ‘’ Category
Coelho Ribeiro & Associados’ cases in Biotech & Life Sciences
Published 01 August 2016 by Rui Botica Santos
Coelho Ribeiro & Associados, Portugal
Representing generic pharmaceutical companies in litigations against other pharmaceutical companies seeking to obtain the suspension of the generic marketing authorizations and the fixing of its public sales price.
... Read moreMason Hayes + Curran’s cases in Biotech & Life Sciences
Published 01 August 2016 by Philip Nolan
Mason Hayes & Curran, Ireland
Advised McKesson Corporation on its acquisition of the pharmaceutical distribution business of Irish FTSE 250 company, UDG Healthcare plc for €408m.
... Read moreClyde & Co’s cases in Biotech & Life Sciences
Published 01 August 2016 by Simon Gamblin
Clyde & Co. LLP, United Kingdom
Patent and contractual due diligence exercises for a UK mid-sized pharma company relating to its proposed acquisitions and licensing-in of medicines.
... Read moreHarlay Avocats’ cases in Biotech & Life Sciences
Published 21 July 2016 by Fabrice Perbost
Harlay Avocats, France
Haylay’s cases in Biotech & Life Sciences
... Read moreAltius’ cases in Biotech & Life Sciences
Published 21 July 2016 by Christophe Ronse
ALTIUS Lawyers, Belgium
Altius’ cases in Biotech & Life Sciences
... Read more